subgroup of
drug)
→
CapableOf
→
enter clinical trials
| Typicality: | 0.574 |
| Saliency: | 0.379 |
| for the treatment of malaria | 4 | purpose |
| new drug → enter → clinical trials | 5 |
| new drug → undergo → clinical trials | 5 |
| new drug → go through → clinical trials | 4 |
| negative | neutral | positive |
| 0.189 | 0.485 | 0.326 |
| Raw frequency | 14 |
| Normalized frequency | 0.379 |
| Modifier score | 1.000 |
| Perplexity | 260.641 |